Differential effect of the p53 inducers Nutlin-3 and RITA on cell lines with different p53 status

被引：0
|
作者：
Weilbacher, A. [1 ,2 ]
Gutekunst, M. [1 ,2 ]
Oren, M. [3 ]
Aulitzky, W. [4 ]
van der Kuip, H. [1 ,2 ]
机构：
[1] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-7000 Stuttgart, Germany
[2] Univ Tubingen, Stuttgart, Germany
[3] Weizmann Inst Sci, Dept Mol Biol, IL-76100 Rehovot, Israel
[4] Robert Bosch Hosp Stuttgart, Dept Internal Med 2, Stuttgart, Germany
来源：
ONKOLOGIE | 2012年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：195 / 196
页数：2
相关论文
共 50 条
  • [21] Comparison of the antitumor effects of an MDM2 inhibitor, nutlin-3, in feline lymphoma cell lines with or without p53 mutation
    Mochizuki, Hiroyuki
    Goto-Koshino, Yuko
    Sato, Masahiko
    Fujino, Yasuhito
    Ohno, Koichi
    Tsujimoto, Hajime
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2012, 147 (3-4) : 187 - 194
  • [22] The MDM2 antagonist nutlin-3 is lethal to mantle cell lymphoma with wild type p53
    Tabe, Yoko
    Szbasigari, Denise
    Rudelius, Martina
    Pittaluga, Stefania
    Raffel, Mark
    BLOOD, 2007, 110 (11) : 415A - 415A
  • [23] Restoration of p53 Pathway by Nutlin-3 Induces Cell Cycle Arrest and Apoptosis in Human Rhabdomyosarcoma Cells
    Miyachi, Mitsuru
    Kakazu, Naoki
    Yagyu, Shigeki
    Katsumi, Yoshiki
    Tsubai-Shimizu, Satoko
    Kikuchi, Ken
    Tsuchiya, Kunihiko
    Iehara, Tomoko
    Hosoi, Hajime
    CLINICAL CANCER RESEARCH, 2009, 15 (12) : 4077 - 4084
  • [24] The Combination of p53 Dendritic Cell Vaccine and Ad-p53 Gene Therapy Against p53 Overexpressing and p53 Deleted Tumor Cell Lines
    Saito, Hiroki
    Kitagawa, Koichi
    Yamasaki, Risa
    Katai, Nami
    Morishita, Naoya
    Kawabata, Masato
    Bautista, Dody
    Dator, Dante
    Shirakawa, Toshiro
    MOLECULAR THERAPY, 2015, 23 : S167 - S167
  • [25] Combination of nutlin-3 and VX-680 selectively targets p53 mutant cells with reversible effects on cells expressing wild-type p53
    C F Cheok
    N Kua
    P Kaldis
    D P Lane
    Cell Death & Differentiation, 2010, 17 : 1486 - 1500
  • [26] Effects of exogenous p53 transduction in thyroid tumor cells with different p53 status
    Moretti, F
    Nanni, S
    Farsetti, A
    Narducci, M
    Crescenzi, M
    Giuliacci, S
    Sacchi, A
    Pontecorvi, A
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (01): : 302 - 308
  • [27] PHARMACOLOGICAL ACTIVATION OF THE p53 PATHWAY BY NUTLIN-3 EXERTS ANTI-TUMORAL EFFECTS IN MEDULLOBLASTOMAS
    Kuenkele, Annette
    De Preter, Katleen
    Heukamp, Lukas
    Thor, Theresa
    Pajtler, Kristian
    Hartmann, Wolfgang
    Mittelbronn, Michel
    Grotzer, Michael
    Deubzer, Hedwig
    Speleman, Frank
    Schramm, Alexander
    Eggert, Angelika
    Schulte, Johannes
    NEURO-ONCOLOGY, 2012, 14 : 88 - 88
  • [28] Small molecule RITA binds to p53, blocks p53–HDM-2 interaction and activates p53 function in tumors
    Natalia Issaeva
    Przemyslaw Bozko
    Martin Enge
    Marina Protopopova
    Lisette G G C Verhoef
    Maria Masucci
    Aladdin Pramanik
    Galina Selivanova
    Nature Medicine, 2004, 10 : 1321 - 1328
  • [29] Combination of nutlin-3 and VX-680 selectively targets p53 mutant cells with reversible effects on cells expressing wild-type p53
    Cheok, C. F.
    Kua, N.
    Kaldis, P.
    Lane, D. P.
    CELL DEATH AND DIFFERENTIATION, 2010, 17 (09): : 1486 - 1500
  • [30] Synergistic induction of p53 mediated apoptosis by valproic acid and nutlin-3 in acute myeloid leukemia
    E McCormack
    I Haaland
    G Venås
    R B Forthun
    S Huseby
    G Gausdal
    S Knappskog
    D R Micklem
    J B Lorens
    Ø Bruserud
    B T Gjertsen
    Leukemia, 2012, 26 : 910 - 917
12345